Related Experiment Video

Updated: Jul 4, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism

Teresa Gómez Del Pulgar1, Fátima Valdés-Mora, Eva Bandrés

  • 1Centro Nacional de Biotecnología, Madrid, Spain.

International Journal of Oncology
|June 26, 2008
PubMed

Insights

Cdc42 overexpression down-regulates the tumor suppressor ID4 in colorectal cancer by inducing promoter methylation. This finding suggests Cdc42 plays a role in colon cancer development and offers potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Cdc42, a Rho GTPase, regulates critical cellular processes including actin cytoskeleton dynamics and cell cycle progression.
  • Aberrant Cdc42 expression is implicated in various cancers.
  • The specific role of Cdc42 in colorectal cancer pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the role of Cdc42 in colorectal cancer development and progression.
  • To determine the effect of Cdc42 on the expression of the tumor suppressor gene ID4.
  • To explore the potential of targeting Cdc42 in colorectal cancer management.

Main Methods:

  • Microarray analysis to compare Cdc42 overexpressing cells with siRNA-treated cells.
  • Quantitative RT-PCR to validate gene expression changes.
  • Methylation-specific PCR and bisulfite sequencing PCR to analyze ID4 promoter methylation status.
  • Analysis of Cdc42 and ID4 expression in colorectal adenocarcinoma patient samples.

Main Results:

  • Cdc42 overexpression led to the down-regulation of the tumor suppressor gene ID4.
  • Cdc42 induced methylation of the ID4 promoter CpG island.
  • Down-regulation of ID4 by Cdc42 was observed in colorectal adenocarcinoma tissues.
  • Cdc42 was overexpressed in 60% of colorectal cancer samples and significantly associated with ID4 silencing (p<0.05).

Conclusions:

  • Cdc42 overexpression contributes to colorectal cancer development by silencing the tumor suppressor ID4 through promoter methylation.
  • Cdc42 is frequently overexpressed in colorectal cancer and its activity is linked to ID4 silencing.
  • Inhibiting Cdc42 activity may represent a therapeutic strategy for colorectal cancer management.

More Related Videos

3D Culturing of Organoids from the Intestinal Villi Epithelium Undergoing Dedifferentiation06:40

3D Culturing of Organoids from the Intestinal Villi Epithelium Undergoing Dedifferentiation

Published on: April 1, 2021

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...